OMALIZUMAB

OMALIZUMAB was reported 87093 times

OMALIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URTICARIA THERMAL 96 0.6761
1 FORCED EXPIRATORY FLOW DECREASED 63 0.6495
2 CHRONIC SPONTANEOUS URTICARIA 740 0.6379
3 URTICARIA PRESSURE 38 0.6333
4 FORCED EXPIRATORY VOLUME DECREASED 1628 0.5740
5 IDIOPATHIC URTICARIA 603 0.5604
6 SMOKE SENSITIVITY 153 0.4968
7 PERFUME SENSITIVITY 266 0.4675
8 ACQUIRED FACTOR V DEFICIENCY 49 0.4455
9 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 392 0.4229
10 BLOOD IMMUNOGLOBULIN E DECREASED 66 0.4099
11 BLOOD IMMUNOGLOBULIN E ABNORMAL 37 0.4066
12 TOTAL LUNG CAPACITY INCREASED 98 0.3603
13 VITAL CAPACITY DECREASED 157 0.3504
14 BLOOD IMMUNOGLOBULIN E INCREASED 827 0.3412
15 COAGULATION FACTOR V LEVEL ABNORMAL 40 0.3252
16 FORCED VITAL CAPACITY DECREASED 208 0.3185
17 HUMIDITY INTOLERANCE 124 0.3100
18 COAGULATION FACTOR DEFICIENCY 49 0.3043
19 REVERSIBLE AIRWAYS OBSTRUCTION 141 0.2776
20 COLD URTICARIA 60 0.2727
21 MAST CELL ACTIVATION SYNDROME 372 0.2650
22 PEAK EXPIRATORY FLOW RATE DECREASED 109 0.2477
23 EXPOSURE TO ALLERGEN 79 0.2476
24 MASTOCYTOSIS 115 0.2431
25 NASAL OEDEMA 394 0.2179
26 ASTHMATIC CRISIS 777 0.2125
27 DUST ALLERGY 207 0.2110
28 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 107 0.2046
29 MECHANICAL URTICARIA 95 0.2026
30 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 39 0.1990
31 ALLERGY TO ANIMAL 210 0.1970
32 PULMONARY FUNCTION TEST ABNORMAL 304 0.1950
33 URTICARIA CHRONIC 106 0.1889
34 LUNG DIFFUSION TEST DECREASED 70 0.1754
35 SPUTUM DISCOLOURED 1657 0.1745
36 ALVEOLAR OSTEITIS 72 0.1702
37 URINARY TRACT DISCOMFORT 78 0.1692
38 OBSTRUCTIVE AIRWAYS DISORDER 1882 0.1690
39 NASAL DISCHARGE DISCOLOURATION 226 0.1638
40 SPIROMETRY ABNORMAL 96 0.1605
41 SENSITIVITY TO WEATHER CHANGE 792 0.1504
42 FACTOR V LEIDEN MUTATION 58 0.1461
43 LOWER RESPIRATORY TRACT CONGESTION 245 0.1439
44 BRONCHIAL SECRETION RETENTION 183 0.1436
45 HYPOVENTILATION 467 0.1432
46 TOTAL LUNG CAPACITY DECREASED 221 0.1383
47 RESPIRATORY TRACT INFLAMMATION 63 0.1352
48 STATUS ASTHMATICUS 63 0.1335
49 NASAL POLYPS 649 0.1317
50 ALLERGIC GRANULOMATOUS ANGIITIS 108 0.1315
51 SPUTUM CULTURE POSITIVE 106 0.1305
52 RESTRICTIVE PULMONARY DISEASE 147 0.1254
53 URTICARIAL VASCULITIS 64 0.1212
54 BREATH SOUNDS ABNORMAL 566 0.1147
55 RHINITIS ALLERGIC 491 0.1102
56 ANIMAL SCRATCH 107 0.1100
57 ASTHMA 12359 0.1092
58 BRONCHIAL WALL THICKENING 75 0.1043
59 ALLERGY TO PLANTS 46 0.1007
60 LUNG HYPERINFLATION 84 0.0977
61 WHEEZING 5674 0.0956
62 RALES 551 0.0948
63 INCREASED VISCOSITY OF BRONCHIAL SECRETION 60 0.0940
64 RUBBER SENSITIVITY 143 0.0933
65 BODY TEMPERATURE DECREASED 914 0.0928
66 MITE ALLERGY 60 0.0916
67 RHONCHI 122 0.0883
68 SINUS PAIN 204 0.0874
69 EOSINOPHIL COUNT ABNORMAL 65 0.0870
70 BRONCHIAL OBSTRUCTION 117 0.0833
71 BLOOD PRESSURE SYSTOLIC INCREASED 1607 0.0823
72 ANAPHYLACTIC REACTION 4550 0.0823
73 INTERCEPTED PRODUCT STORAGE ERROR 283 0.0792
74 SKIN PLAQUE 651 0.0771
75 EAR PRURITUS 268 0.0764
76 SINUS POLYP 43 0.0745
77 VACCINATION SITE PAIN 42 0.0730
78 PULMONARY FUNCTION TEST DECREASED 319 0.0728
79 RESPIRATORY RATE INCREASED 644 0.0725
80 UPPER-AIRWAY COUGH SYNDROME 597 0.0724
81 BRONCHIECTASIS 485 0.0719
82 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 145 0.0710
83 DIAPHRAGMATIC DISORDER 54 0.0706
84 TRYPTASE INCREASED 50 0.0700
85 URTICARIA 11739 0.0700
86 MIDDLE INSOMNIA 1275 0.0682
87 CHEST X-RAY ABNORMAL 209 0.0681
88 FOOD ALLERGY 524 0.0678
89 INCREASED BRONCHIAL SECRETION 171 0.0668
90 THROAT CLEARING 246 0.0656
91 ALLERGY TO CHEMICALS 80 0.0642
92 NASAL PRURITUS 80 0.0638
93 FULL BLOOD COUNT ABNORMAL 673 0.0636
94 INJECTION SITE SCAB 60 0.0622
95 MYCOTIC ALLERGY 53 0.0620
96 NO ADVERSE EVENT 11200 0.0618
97 CLAUSTROPHOBIA 67 0.0614
98 TERMINAL INSOMNIA 107 0.0604
99 BACTERIAL DISEASE CARRIER 43 0.0590
100 SERUM SICKNESS 154 0.0552
101 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 74 0.0548
102 PRODUCTIVE COUGH 2613 0.0547
103 DYSPNOEA AT REST 155 0.0534
104 SKIN SENSITISATION 55 0.0531
105 RESPIRATORY TRACT CONGESTION 828 0.0521
106 ANGIOEDEMA 2302 0.0520
107 PARANASAL SINUS DISCOMFORT 196 0.0517
108 PHARYNGEAL SWELLING 504 0.0515
109 CONJUNCTIVITIS ALLERGIC 76 0.0513
110 CREPITATIONS 152 0.0510
111 PHARYNGEAL PARAESTHESIA 78 0.0491
112 SEASONAL ALLERGY 691 0.0488
113 LUNG OPACITY 127 0.0481
114 RESPIRATORY TRACT INFECTION 1245 0.0478
115 EAR CONGESTION 129 0.0476
116 SECRETION DISCHARGE 578 0.0461
117 EOSINOPHIL COUNT INCREASED 382 0.0458
118 INJECTION RELATED REACTION 75 0.0454
119 SPUTUM RETENTION 45 0.0454
120 SPUTUM INCREASED 98 0.0453
121 RHINITIS 359 0.0445
122 BRONCHIAL DISORDER 69 0.0443
123 TUNNEL VISION 81 0.0432
124 CATARRH 39 0.0431
125 CHRONIC SINUSITIS 160 0.0426
126 NASAL INFLAMMATION 45 0.0426
127 STEROID DIABETES 63 0.0420
128 SENSE OF OPPRESSION 49 0.0416
129 SINUS CONGESTION 563 0.0416
130 MULTIPLE ALLERGIES 322 0.0410
131 SCRATCH 433 0.0410
132 MATERNAL EXPOSURE TIMING UNSPECIFIED 153 0.0407
133 EAR SWELLING 86 0.0406
134 OTORRHOEA 70 0.0401
135 BLOOD LACTIC ACID INCREASED 211 0.0400
136 PULMONARY PAIN 116 0.0397
137 BODY TEMPERATURE ABNORMAL 72 0.0391
138 INTERCEPTED MEDICATION ERROR 179 0.0386
139 HYPOSMIA 58 0.0385
140 DEVICE DEFECTIVE 668 0.0385
141 NASAL CONGESTION 2225 0.0378
142 BRONCHOSPASM 532 0.0372
143 ORAL PRURITUS 85 0.0370
144 ARTHROPOD STING 60 0.0360
145 BRONCHIAL HYPERREACTIVITY 43 0.0357
146 PLEURITIC PAIN 96 0.0347
147 TEMPERATURE INTOLERANCE 354 0.0343
148 SNEEZING 768 0.0342
149 NASAL DISORDER 90 0.0338
150 MOUTH SWELLING 195 0.0338
151 PHARYNGEAL DISORDER 97 0.0337
152 CONCOMITANT DISEASE AGGRAVATED 205 0.0332
153 NASAL OBSTRUCTION 62 0.0330
154 NOCTURNAL DYSPNOEA 41 0.0321
155 RESPIRATORY RATE DECREASED 101 0.0321
156 BODY MASS INDEX INCREASED 43 0.0318
157 SYMPTOM RECURRENCE 190 0.0317
158 NASAL SEPTUM DEVIATION 62 0.0317
159 LOWER RESPIRATORY TRACT INFECTION 1416 0.0311
160 PAPULE 219 0.0311
161 THROAT TIGHTNESS 831 0.0307
162 ANAPHYLACTOID REACTION 126 0.0306
163 EYE ALLERGY 47 0.0303
164 POLYMYALGIA RHEUMATICA 96 0.0302
165 OBSTRUCTIVE SLEEP APNOEA SYNDROME 44 0.0302
166 DYSPNOEA EXERTIONAL 1131 0.0300
167 INJECTION SITE HYPOAESTHESIA 42 0.0293
168 PULMONARY CONGESTION 383 0.0290
169 BRONCHITIS 2139 0.0289
170 FRUSTRATION TOLERANCE DECREASED 233 0.0288
171 OEDEMA 1563 0.0288
172 CHEST DISCOMFORT 2945 0.0287
173 WOUND SECRETION 110 0.0281
174 BLADDER PAIN 89 0.0280
175 UPPER RESPIRATORY TRACT CONGESTION 81 0.0280
176 LUNG INFECTION 433 0.0278
177 LIP SWELLING 902 0.0271
178 APHONIA 378 0.0271
179 RHINORRHOEA 1736 0.0268
180 RESPIRATORY DISORDER 794 0.0265
181 ANAPHYLACTIC SHOCK 673 0.0261
182 EAR PAIN 506 0.0260
183 RESPIRATORY SYMPTOM 74 0.0260
184 LIGAMENT SPRAIN 257 0.0260
185 WOUND COMPLICATION 88 0.0256
186 COUGH 7188 0.0256
187 INFLUENZA 2833 0.0254
188 BLOOD PRESSURE DIASTOLIC INCREASED 117 0.0253
189 INCREASED UPPER AIRWAY SECRETION 130 0.0253
190 HYPERVENTILATION 146 0.0252
191 SARCOIDOSIS 118 0.0248
192 PULMONARY MASS 369 0.0247
193 SERUM FERRITIN DECREASED 42 0.0243
194 FOOD INTOLERANCE 89 0.0243
195 SNORING 90 0.0238
196 VASCULITIS 277 0.0238
197 BLOOD PRESSURE DIASTOLIC DECREASED 175 0.0237
198 OROPHARYNGEAL PAIN 2164 0.0234
199 OROPHARYNGEAL DISCOMFORT 209 0.0231
200 HEART RATE INCREASED 2285 0.0230
201 EXPOSURE TO SARS-COV-2 39 0.0229
202 PARAESTHESIA ORAL 331 0.0229
203 RED BLOOD CELL COUNT INCREASED 63 0.0228
204 PAINFUL RESPIRATION 54 0.0224
205 SINUSITIS 2290 0.0223
206 LABYRINTHITIS 56 0.0221
207 LIPOMA 57 0.0220
208 EOSINOPHILIA 385 0.0219
209 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 373 0.0219
210 NASOPHARYNGITIS 4041 0.0219
211 LIGAMENT RUPTURE 96 0.0217
212 VERTIGO POSITIONAL 38 0.0217
213 VIRAL INFECTION 722 0.0217
214 ACUTE SINUSITIS 37 0.0214
215 NEEDLE ISSUE 620 0.0213
216 EYE OEDEMA 52 0.0212
217 LARYNGOSPASM 57 0.0212
218 EXERCISE TOLERANCE DECREASED 121 0.0210
219 MATERNAL EXPOSURE BEFORE PREGNANCY 143 0.0209
220 VOCAL CORD DISORDER 41 0.0208
221 SUFFOCATION FEELING 51 0.0205
222 LARYNGEAL OEDEMA 126 0.0204
223 DRUG DELIVERY SYSTEM MALFUNCTION 104 0.0203
224 ASPHYXIA 165 0.0202
225 SWELLING FACE 1315 0.0202
226 RESPIRATORY TRACT INFECTION VIRAL 47 0.0202
227 BLOOD COUNT ABNORMAL 304 0.0200
228 BLOOD PRESSURE INCREASED 3064 0.0200
229 PHARYNGITIS 247 0.0199
230 ANIMAL BITE 53 0.0199
231 HEREDITARY ANGIOEDEMA 212 0.0197
232 SWOLLEN TONGUE 615 0.0197
233 EAR DISCOMFORT 202 0.0197
234 TONGUE OEDEMA 75 0.0196
235 PERIORBITAL SWELLING 111 0.0196
236 CHOKING SENSATION 108 0.0196
237 PREGNANCY 390 0.0195
238 HYPERSENSITIVITY 3611 0.0194
239 QUALITY OF LIFE DECREASED 259 0.0193
240 EAR INFECTION 507 0.0190
241 ILLNESS 1951 0.0189
242 EYE PRURITUS 631 0.0188
243 MYOPATHY 162 0.0187
244 INFECTIOUS MONONUCLEOSIS 42 0.0187
245 THROAT IRRITATION 840 0.0187
246 DYSPNOEA 10547 0.0186
247 MIDDLE EAR EFFUSION 41 0.0186
248 LUNG DISORDER 910 0.0185
249 PLATELET COUNT INCREASED 242 0.0185
250 PERIARTHRITIS 42 0.0184
251 EYE SWELLING 686 0.0184
252 SINUS DISORDER 365 0.0184
253 PIGMENTATION DISORDER 113 0.0183
254 CYSTIC FIBROSIS 101 0.0182
255 BLOOD IRON DECREASED 216 0.0182
256 BLOOD IMMUNOGLOBULIN G DECREASED 45 0.0181
257 VIRAL UPPER RESPIRATORY TRACT INFECTION 86 0.0181
258 EMPHYSEMA 182 0.0180
259 BODY TEMPERATURE INCREASED 367 0.0180
260 EOSINOPHILIC OESOPHAGITIS 49 0.0177
261 SWELLING 1651 0.0176
262 RESPIRATION ABNORMAL 120 0.0174
263 LACRIMATION INCREASED 526 0.0174
264 UPPER RESPIRATORY TRACT INFECTION 804 0.0174
265 SKIN LACERATION 188 0.0173
266 SINUS HEADACHE 102 0.0172
267 PRURITUS 6575 0.0171
268 CHOKING 333 0.0171
269 SUSPECTED OFF LABEL USE 77 0.0170
270 DYSPHONIA 993 0.0170
271 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 884 0.0169
272 INFECTION SUSCEPTIBILITY INCREASED 37 0.0169
273 PNEUMONIA 5462 0.0169
274 SYRINGE ISSUE 295 0.0168
275 WRIST FRACTURE 202 0.0168
276 STRIDOR 48 0.0163
277 SWELLING OF EYELID 102 0.0162
278 TYPE I HYPERSENSITIVITY 57 0.0162
279 HYPOPNOEA 56 0.0161
280 PHARYNGEAL OEDEMA 247 0.0160
281 OTITIS MEDIA 53 0.0160
282 SENSATION OF FOREIGN BODY 135 0.0160
283 CONCUSSION 124 0.0160
284 SLEEP APNOEA SYNDROME 305 0.0160
285 DECREASED ACTIVITY 170 0.0157
286 FOOD POISONING 84 0.0157
287 PRODUCT COMPLAINT 394 0.0155
288 THERAPY PARTIAL RESPONDER 241 0.0154
289 BLOOD CALCIUM INCREASED 134 0.0153
290 POLYP 100 0.0153
291 AUTOIMMUNE DISORDER 148 0.0152
292 FEAR OF INJECTION 108 0.0151
293 ARTHROPOD BITE 111 0.0150
294 INJECTION SITE HYPERSENSITIVITY 46 0.0147
295 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 80 0.0147
296 SKIN LESION 401 0.0146
297 UMBILICAL HERNIA 68 0.0145
298 BLOOD TEST ABNORMAL 204 0.0145
299 BRONCHIOLITIS 51 0.0145
300 GASTROENTERITIS VIRAL 260 0.0144
301 ASPERGILLUS INFECTION 94 0.0143
302 PRODUCT SUPPLY ISSUE 102 0.0143
303 RED CELL DISTRIBUTION WIDTH INCREASED 59 0.0142
304 HYPOKINESIA 206 0.0142
305 LIP OEDEMA 60 0.0142
306 APPARENT DEATH 51 0.0141
307 OVERWEIGHT 76 0.0141
308 INJECTION SITE DISCOMFORT 148 0.0141
309 ACCIDENT 168 0.0141
310 MIGRAINE 1329 0.0139
311 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 986 0.0138
312 ECZEMA 718 0.0137
313 CLAVICLE FRACTURE 52 0.0136
314 SKIN HYPERTROPHY 38 0.0135
315 DISCOMFORT 822 0.0135
316 HEART RATE ABNORMAL 75 0.0134
317 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 645 0.0134
318 DERMATITIS CONTACT 152 0.0133
319 MALAISE 5790 0.0132
320 TOOTH ABSCESS 134 0.0131
321 PHARYNGITIS STREPTOCOCCAL 141 0.0130
322 AUTOIMMUNE THYROIDITIS 49 0.0129
323 LIMB INJURY 352 0.0129
324 MASS 181 0.0129
325 STREPTOCOCCAL INFECTION 72 0.0129
326 OXYGEN SATURATION DECREASED 723 0.0129
327 WEIGHT DECREASED 3578 0.0128
328 PRODUCT AVAILABILITY ISSUE 291 0.0128
329 CUSHINGOID 41 0.0128
330 PYELONEPHRITIS 110 0.0127
331 ASPIRATION 139 0.0127
332 OFF LABEL USE 11096 0.0127
333 EAR DISORDER 58 0.0127
334 RESPIRATORY SYNCYTIAL VIRUS INFECTION 110 0.0126
335 SPINAL CORD COMPRESSION 49 0.0126
336 BLOOD PRESSURE DECREASED 835 0.0126
337 THERMAL BURN 89 0.0125
338 ADRENAL INSUFFICIENCY 152 0.0125
339 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2252 0.0125
340 SKIN ABRASION 59 0.0125
341 WEIGHT INCREASED 2784 0.0124
342 OBESITY 198 0.0124
343 HYPOAESTHESIA ORAL 187 0.0124
344 MUSCULOSKELETAL CHEST PAIN 191 0.0123
345 POOR QUALITY SLEEP 265 0.0123
346 ROSACEA 57 0.0122
347 SKIN INFECTION 137 0.0122
348 FEELING HOT 745 0.0121
349 SKIN REACTION 170 0.0121
350 DRY THROAT 122 0.0120
351 GASTROENTERITIS 175 0.0120
352 FIBROMYALGIA 291 0.0120
353 LEFT VENTRICULAR HYPERTROPHY 51 0.0119
354 BREAST MASS 80 0.0119
355 ERYTHEMA 2445 0.0119
356 FACIAL PAIN 106 0.0119
357 BACK INJURY 128 0.0118
358 SARS-COV-2 TEST POSITIVE 155 0.0117
359 CHEST PAIN 2170 0.0117
360 HAND FRACTURE 83 0.0117
361 ANEURYSM 58 0.0116
362 IMMUNODEFICIENCY 173 0.0116
363 INFLUENZA LIKE ILLNESS 948 0.0115
364 IMMUNOSUPPRESSION 101 0.0114
365 PHOTOSENSITIVITY REACTION 189 0.0114
366 UPPER LIMB FRACTURE 228 0.0114
367 JOINT INJURY 244 0.0114
368 GASTROOESOPHAGEAL REFLUX DISEASE 914 0.0113
369 GENERAL PHYSICAL CONDITION ABNORMAL 77 0.0113
370 PRODUCT STORAGE ISSUE 43 0.0113
371 HAEMOPTYSIS 316 0.0113
372 PSEUDOMONAS INFECTION 97 0.0113
373 PERIPHERAL SWELLING 1742 0.0113
374 PRODUCT TEMPERATURE EXCURSION ISSUE 58 0.0113
375 RIB FRACTURE 230 0.0112
376 RESPIRATORY DISTRESS 308 0.0111
377 PNEUMONIA FUNGAL 44 0.0111
378 CONTUSION 1064 0.0110
379 NERVE COMPRESSION 102 0.0110
380 PARANASAL SINUS HYPERSECRETION 42 0.0110
381 SENSITIVE SKIN 81 0.0110
382 PERIORBITAL OEDEMA 57 0.0110
383 JOINT DISLOCATION 116 0.0110
384 IMMUNE SYSTEM DISORDER 144 0.0109
385 ATTENTION DEFICIT HYPERACTIVITY DISORDER 46 0.0109
386 TONSILLITIS 57 0.0109
387 HERPES ZOSTER 622 0.0108
388 BURNING SENSATION 758 0.0108
389 BLOOD PRESSURE SYSTOLIC DECREASED 49 0.0108
390 NONSPECIFIC REACTION 59 0.0107
391 CARDIAC MURMUR 93 0.0107
392 BLOOD POTASSIUM DECREASED 323 0.0107
393 PULMONARY THROMBOSIS 116 0.0106
394 TYPE 2 DIABETES MELLITUS 357 0.0106
395 PHLEBITIS 54 0.0105
396 PRODUCT DOSE OMISSION ISSUE 3099 0.0105
397 OBSTRUCTION 42 0.0105
398 NEUTROPHIL COUNT INCREASED 107 0.0104
399 MYALGIA 1762 0.0104
400 BRAIN FOG 161 0.0103
401 THERAPEUTIC RESPONSE SHORTENED 340 0.0102
402 FACE OEDEMA 172 0.0102
403 LYMPHADENOPATHY 360 0.0102
404 HEART RATE DECREASED 357 0.0102
405 VITAMIN B12 DEFICIENCY 41 0.0101
406 VARICOSE VEIN 52 0.0101
407 SKIN MASS 67 0.0100
408 SLEEP DISORDER 707 0.0100
409 INTENTIONAL PRODUCT USE ISSUE 877 0.0100
410 MUSCLE DISORDER 81 0.0100
411 HEAD DISCOMFORT 177 0.0100
412 FEELING COLD 278 0.0100
413 FOOT FRACTURE 189 0.0100
414 WEIGHT FLUCTUATION 104 0.0099
415 ILL-DEFINED DISORDER 602 0.0099
416 SKIN SWELLING 86 0.0099
417 PRODUCT PRESCRIBING ERROR 236 0.0099
418 THYROID MASS 38 0.0099
419 INTRACRANIAL PRESSURE INCREASED 55 0.0099
420 FACIAL PARALYSIS 84 0.0098
421 GLUCOSE TOLERANCE IMPAIRED 58 0.0098
422 ORAL CANDIDIASIS 129 0.0098
423 INFLAMMATION 505 0.0098
424 BURSITIS 118 0.0097
425 EXPOSURE VIA SKIN CONTACT 252 0.0097
426 GESTATIONAL DIABETES 46 0.0096
427 FEELING OF DESPAIR 45 0.0096
428 EYE INFLAMMATION 92 0.0096
429 THERAPEUTIC RESPONSE DECREASED 584 0.0096
430 LIMB DISCOMFORT 298 0.0096
431 PYREXIA 3319 0.0096
432 DYSPHEMIA 42 0.0096
433 NAIL DISCOLOURATION 37 0.0094
434 DIZZINESS POSTURAL 91 0.0094
435 MATERNAL EXPOSURE DURING PREGNANCY 836 0.0094
436 ARTHRALGIA 3885 0.0093
437 NASAL DISCOMFORT 74 0.0093
438 PULMONARY FIBROSIS 179 0.0093
439 MOVEMENT DISORDER 297 0.0092
440 ABDOMINAL HERNIA 42 0.0092
441 PRURITUS GENERALISED 199 0.0092
442 INTERVERTEBRAL DISC PROTRUSION 201 0.0092
443 TOOTH INFECTION 121 0.0092
444 ANOSMIA 132 0.0091
445 RASH VESICULAR 44 0.0091
446 WOUND 254 0.0091
447 LOCALISED OEDEMA 42 0.0091
448 DECREASED IMMUNE RESPONSIVENESS 89 0.0091
449 SKIN ATROPHY 52 0.0090
450 CELLULITIS 455 0.0090
451 RASH ERYTHEMATOUS 426 0.0089
452 BRUXISM 48 0.0089
453 HEADACHE 5574 0.0089
454 TONGUE DISORDER 64 0.0088
455 VITAMIN D DEFICIENCY 86 0.0088
456 POST PROCEDURAL COMPLICATION 169 0.0088
457 INJECTION SITE URTICARIA 214 0.0087
458 MUSCULOSKELETAL DISCOMFORT 150 0.0087
459 BENIGN PROSTATIC HYPERPLASIA 45 0.0087
460 TONGUE DISCOLOURATION 38 0.0087
461 BACTERIAL INFECTION 162 0.0087
462 UTERINE LEIOMYOMA 63 0.0086
463 POSTOPERATIVE WOUND INFECTION 58 0.0086
464 DIABETES MELLITUS 652 0.0085
465 ROAD TRAFFIC ACCIDENT 356 0.0085
466 SCAB 97 0.0085
467 HIATUS HERNIA 110 0.0085
468 CONJUNCTIVITIS 157 0.0085
469 BREAST PAIN 90 0.0084
470 INJECTION SITE INFLAMMATION 42 0.0084
471 PLEURISY 50 0.0084
472 ENDOMETRIOSIS 40 0.0084
473 CHILLS 981 0.0084
474 POST PROCEDURAL INFECTION 68 0.0084
475 ABORTION SPONTANEOUS 334 0.0083
476 FEAR 224 0.0083
477 NERVOUSNESS 432 0.0083
478 HYPOGAMMAGLOBULINAEMIA 54 0.0082
479 BLOOD URINE PRESENT 156 0.0082
480 PANIC REACTION 59 0.0082
481 BLISTER 459 0.0082
482 PNEUMONIA BACTERIAL 75 0.0082
483 FLANK PAIN 76 0.0081
484 KIDNEY INFECTION 159 0.0081
485 ORAL HERPES 158 0.0081
486 SPEECH DISORDER 424 0.0081
487 MUSCLE STRAIN 70 0.0081
488 DIVERTICULITIS 224 0.0081
489 MOBILITY DECREASED 579 0.0081
490 FATIGUE 6263 0.0080
491 PARAESTHESIA 1262 0.0080
492 TENDONITIS 124 0.0080
493 COVID-19 1405 0.0080
494 HYPOXIA 281 0.0080
495 CYST 99 0.0080
496 RASH 3472 0.0080
497 ALOPECIA 1561 0.0079
498 PROCEDURAL PAIN 220 0.0079
499 DERMATITIS 165 0.0079
500 THYROID DISORDER 121 0.0078
501 PAIN IN EXTREMITY 2297 0.0078
502 INSOMNIA 2068 0.0078
503 SKIN WARM 45 0.0077
504 BONE PAIN 452 0.0077
505 OEDEMA PERIPHERAL 940 0.0077
506 SKIN HAEMORRHAGE 114 0.0077
507 CARDIOMEGALY 94 0.0076
508 HEART RATE IRREGULAR 172 0.0076
509 NEPHROLITHIASIS 349 0.0076
510 GENERALISED OEDEMA 94 0.0076
511 SENSORY LOSS 61 0.0076
512 GAIT INABILITY 252 0.0075
513 MUSCLE TIGHTNESS 122 0.0075
514 NECK PAIN 420 0.0075
515 FEELING OF BODY TEMPERATURE CHANGE 44 0.0075
516 NASAL DRYNESS 47 0.0075
517 WOUND INFECTION 82 0.0075
518 MUSCULOSKELETAL PAIN 392 0.0075
519 IMPAIRED QUALITY OF LIFE 107 0.0074
520 INJECTION SITE REACTION 512 0.0074
521 PAIN 4566 0.0074
522 PAROSMIA 56 0.0074
523 SKIN DISCOLOURATION 341 0.0074
524 CYSTITIS 236 0.0074
525 BLOOD PRESSURE ABNORMAL 147 0.0074
526 ARTHRITIS 580 0.0074
527 HYPERTENSION 1559 0.0074
528 ANXIETY 2086 0.0073
529 WHITE BLOOD CELL COUNT INCREASED 281 0.0073
530 SUNBURN 54 0.0072
531 FEELING ABNORMAL 1730 0.0072
532 FORMICATION 50 0.0072
533 PALLOR 195 0.0072
534 FLUSHING 724 0.0071
535 DIZZINESS 3548 0.0071
536 ANKLE FRACTURE 110 0.0071
537 RASH PRURITIC 385 0.0071
538 TENDERNESS 74 0.0071
539 ACCIDENTAL EXPOSURE TO PRODUCT 718 0.0070
540 SYNCOPE 695 0.0069
541 MENTAL DISORDER 302 0.0069
542 OSTEOARTHRITIS 294 0.0069
543 ATELECTASIS 67 0.0069
544 BACK PAIN 1610 0.0069
545 PRODUCT STORAGE ERROR 604 0.0069
546 HERNIA 133 0.0069
547 NEURALGIA 167 0.0069
548 LOCALISED INFECTION 166 0.0069
549 ECCHYMOSIS 47 0.0068
550 INJECTION SITE SWELLING 525 0.0068
551 PARALYSIS 98 0.0068
552 TACHYCARDIA 608 0.0068
553 COELIAC DISEASE 67 0.0068
554 COLD SWEAT 120 0.0068
555 RASH MACULAR 237 0.0068
556 PANIC ATTACK 247 0.0068
557 BLOOD PRESSURE FLUCTUATION 162 0.0067
558 HYPOAESTHESIA 1010 0.0067
559 SKIN DISORDER 225 0.0067
560 INFECTION 976 0.0067
561 EYE INFECTION 76 0.0067
562 VERTIGO 407 0.0067
563 INJECTION SITE PRURITUS 446 0.0067
564 SPINAL PAIN 78 0.0067
565 THERAPEUTIC PRODUCT EFFECT DECREASED 296 0.0066
566 APHTHOUS ULCER 51 0.0066
567 HYPERAESTHESIA 54 0.0066
568 CANDIDA INFECTION 111 0.0066
569 ORAL DISCOMFORT 91 0.0065
570 DRUG INEFFECTIVE 8624 0.0065
571 HYPOACUSIS 281 0.0065
572 THERAPY NON-RESPONDER 293 0.0065
573 PNEUMONITIS 177 0.0065
574 TYPE 1 DIABETES MELLITUS 39 0.0065
575 LIVER FUNCTION TEST INCREASED 139 0.0065
576 EYE DISCHARGE 67 0.0064
577 AORTIC ANEURYSM 49 0.0064
578 VOMITING 3022 0.0064
579 GENERAL PHYSICAL HEALTH DETERIORATION 743 0.0064
580 TACHYPNOEA 87 0.0064
581 LYMPHOMA 98 0.0063
582 MYASTHENIA GRAVIS 51 0.0063
583 OVARIAN CYST 63 0.0063
584 DEVICE ISSUE 563 0.0063
585 CLOSTRIDIUM DIFFICILE INFECTION 137 0.0063
586 MUSCULOSKELETAL STIFFNESS 548 0.0062
587 CYANOSIS 98 0.0062
588 GLAUCOMA 120 0.0062
589 CARPAL TUNNEL SYNDROME 87 0.0062
590 GOUT 111 0.0062
591 INJECTION SITE BRUISING 490 0.0061
592 GASTROINTESTINAL DISORDER 550 0.0061
593 UNDERDOSE 447 0.0061
594 FOREIGN BODY SENSATION IN EYES 39 0.0061
595 POST-TRAUMATIC STRESS DISORDER 41 0.0061
596 TRANSIENT ISCHAEMIC ATTACK 206 0.0061
597 INTENTIONAL DOSE OMISSION 174 0.0061
598 STAPHYLOCOCCAL INFECTION 201 0.0061
599 GAIT DISTURBANCE 1160 0.0061
600 HAEMATOMA 157 0.0061
601 PRODUCT DISTRIBUTION ISSUE 56 0.0060
602 ROTATOR CUFF SYNDROME 77 0.0060
603 APPENDICITIS 56 0.0060
604 SCOLIOSIS 37 0.0060
605 PALPITATIONS 699 0.0060
606 BRONCHOPULMONARY ASPERGILLOSIS 46 0.0059
607 GASTROINTESTINAL INFECTION 53 0.0059
608 RASH PUSTULAR 43 0.0059
609 LIQUID PRODUCT PHYSICAL ISSUE 43 0.0059
610 HYPERTHERMIA 45 0.0059
611 CRYING 214 0.0059
612 BLOOD CHOLESTEROL INCREASED 274 0.0059
613 ARTERIAL OCCLUSIVE DISEASE 46 0.0058
614 FUNGAL INFECTION 195 0.0058
615 EYELID OEDEMA 68 0.0058
616 PREMATURE DELIVERY 93 0.0058
617 PRESYNCOPE 141 0.0058
618 OSTEOPOROSIS 238 0.0058
619 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 99 0.0058
620 INJECTION SITE PAIN 1768 0.0058
621 PAIN OF SKIN 155 0.0058
622 TRANSAMINASES INCREASED 128 0.0058
623 HYPERHIDROSIS 740 0.0057
624 DYSPHAGIA 545 0.0057
625 SPINAL DISORDER 54 0.0057
626 RED BLOOD CELL SEDIMENTATION RATE INCREASED 63 0.0057
627 TOOTHACHE 103 0.0057
628 OSTEOPENIA 86 0.0057
629 LUNG INFILTRATION 50 0.0057
630 ASTHENIA 2126 0.0056
631 ACCIDENTAL UNDERDOSE 81 0.0056
632 URINARY TRACT INFECTION 956 0.0056
633 ABDOMINAL DISTENSION 584 0.0056
634 TINNITUS 257 0.0056
635 PRODUCT ADMINISTRATION ERROR 113 0.0056
636 SCIATICA 89 0.0056
637 PETECHIAE 58 0.0056
638 FURUNCLE 44 0.0055
639 JOINT SWELLING 667 0.0055
640 INCORRECT DOSE ADMINISTERED 1261 0.0055
641 CATARACT 327 0.0055
642 HYPERCHOLESTEROLAEMIA 53 0.0055
643 DERMATITIS ALLERGIC 69 0.0055
644 OCULAR HYPERAEMIA 259 0.0055
645 ABDOMINAL PAIN 1261 0.0054
646 PRODUCT DISPENSING ERROR 118 0.0054
647 EATING DISORDER 115 0.0054
648 HYPERGLYCAEMIA 196 0.0054
649 DEPRESSED MOOD 284 0.0054
650 OCULAR DISCOMFORT 60 0.0053
651 HOT FLUSH 402 0.0053
652 FALL 1775 0.0053
653 REBOUND EFFECT 60 0.0053
654 LEUKAEMIA 50 0.0053
655 BODY HEIGHT DECREASED 56 0.0052
656 ANGINA PECTORIS 150 0.0052
657 HYPOTHYROIDISM 167 0.0052
658 CONDITION AGGRAVATED 1580 0.0052
659 MENSTRUAL DISORDER 43 0.0052
660 PNEUMOTHORAX 82 0.0052
661 PEMPHIGOID 39 0.0052
662 TENDON PAIN 39 0.0051
663 LUNG NEOPLASM MALIGNANT 210 0.0051
664 INJECTION SITE WARMTH 105 0.0051
665 LOWER LIMB FRACTURE 98 0.0051
666 GASTRITIS 134 0.0051
667 DYSURIA 187 0.0051
668 MALIGNANT MELANOMA 68 0.0051
669 OPTIC NEURITIS 46 0.0051
670 INJECTION SITE RASH 155 0.0050
671 MUSCULAR WEAKNESS 574 0.0050
672 SENSORY DISTURBANCE 81 0.0050
673 HYPERSOMNIA 144 0.0050
674 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 234 0.0050
675 SLUGGISHNESS 51 0.0050
676 GRIP STRENGTH DECREASED 44 0.0050
677 SPINAL FRACTURE 100 0.0050
678 IRRITABLE BOWEL SYNDROME 107 0.0050
679 INJECTION SITE ERYTHEMA 618 0.0050
680 NODULE 65 0.0050
681 SKIN BURNING SENSATION 355 0.0050
682 ARRHYTHMIA 233 0.0049
683 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 993 0.0049
684 LOSS OF CONSCIOUSNESS 627 0.0049
685 PERIPHERAL COLDNESS 67 0.0049
686 SOMNOLENCE 980 0.0049
687 ABDOMINAL PAIN UPPER 1001 0.0049
688 DRUG EXPOSURE DURING PREGNANCY 165 0.0048
689 PERICARDITIS 81 0.0048
690 EYE DISORDER 158 0.0048
691 DYSSTASIA 140 0.0048
692 TREMOR 789 0.0047
693 INFUSION SITE ERYTHEMA 40 0.0047
694 BLOOD DISORDER 38 0.0047
695 ADVERSE REACTION 62 0.0047
696 BONE DISORDER 85 0.0047
697 CHOLELITHIASIS 152 0.0046
698 DRY EYE 231 0.0046
699 TOOTH FRACTURE 51 0.0046
700 PRODUCT USE IN UNAPPROVED INDICATION 1146 0.0046
701 JOINT STIFFNESS 121 0.0046
702 DISEASE RECURRENCE 219 0.0046
703 FRACTURE 87 0.0046
704 DEVICE MALFUNCTION 322 0.0046
705 MUSCLE SPASMS 836 0.0046
706 BACK DISORDER 74 0.0045
707 THROMBOSIS 366 0.0045
708 DYSPEPSIA 447 0.0045
709 SYSTEMIC LUPUS ERYTHEMATOSUS 161 0.0045
710 NIGHT SWEATS 145 0.0045
711 PULMONARY EMBOLISM 427 0.0045
712 CARDIAC DISORDER 420 0.0045
713 ACNE 337 0.0044
714 DEAFNESS 116 0.0044
715 HYPERTENSIVE CRISIS 49 0.0044
716 IMPAIRED GASTRIC EMPTYING 60 0.0044
717 HEAD INJURY 139 0.0044
718 DYSARTHRIA 165 0.0044
719 HYPERTHYROIDISM 63 0.0043
720 RETINAL DETACHMENT 40 0.0043
721 EYE HAEMORRHAGE 58 0.0043
722 FEEDING DISORDER 88 0.0043
723 EPISTAXIS 324 0.0043
724 BLOOD GLUCOSE ABNORMAL 80 0.0043
725 BLADDER DISORDER 43 0.0043
726 INJECTION SITE IRRITATION 55 0.0043
727 PRODUCT CONTAINER ISSUE 37 0.0043
728 PRODUCT PACKAGING ISSUE 41 0.0043
729 EXOSTOSIS 39 0.0043
730 NEOPLASM 49 0.0043
731 ACUTE RESPIRATORY FAILURE 82 0.0043
732 MEMORY IMPAIRMENT 579 0.0042
733 BREAST CANCER 392 0.0042
734 DRUG INTOLERANCE 402 0.0042
735 DERMATITIS ATOPIC 219 0.0041
736 ULCER 66 0.0041
737 BRAIN NEOPLASM 38 0.0041
738 INJECTION SITE HAEMATOMA 60 0.0041
739 TENDON RUPTURE 51 0.0041
740 MUSCLE ATROPHY 52 0.0041
741 SALIVARY HYPERSECRETION 41 0.0041
742 NAUSEA 3225 0.0041
743 BALANCE DISORDER 351 0.0041
744 RENAL PAIN 43 0.0041
745 PHOTOPHOBIA 76 0.0040
746 COLON CANCER 60 0.0040
747 DRUG EFFECT LESS THAN EXPECTED 59 0.0040
748 HEPATIC STEATOSIS 74 0.0040
749 SCAR 68 0.0040
750 INTENTIONAL PRODUCT MISUSE 347 0.0040
751 PREMATURE BABY 119 0.0039
752 SKIN CANCER 85 0.0039
753 DEPRESSION 896 0.0039
754 EYELID PTOSIS 40 0.0039
755 TREATMENT FAILURE 324 0.0039
756 DRY SKIN 521 0.0039
757 DRY MOUTH 315 0.0039
758 INFUSION SITE PAIN 50 0.0039
759 HUNGER 54 0.0039
760 ABDOMINAL DISCOMFORT 650 0.0039
761 VISION BLURRED 532 0.0039
762 MACULAR DEGENERATION 46 0.0038
763 C-REACTIVE PROTEIN INCREASED 140 0.0038
764 HAEMORRHAGE 402 0.0038
765 LETHARGY 221 0.0038
766 POLLAKIURIA 160 0.0038
767 THIRST 68 0.0038
768 EXPOSURE DURING PREGNANCY 236 0.0038
769 AMNESIA 247 0.0038
770 PRODUCT PREPARATION ERROR 78 0.0038
771 INSURANCE ISSUE 58 0.0038
772 MUSCLE TWITCHING 87 0.0038
773 HYPERLIPIDAEMIA 45 0.0038
774 MICTURITION URGENCY 43 0.0038
775 INJECTION SITE DISCOLOURATION 47 0.0038
776 MYOCARDITIS 43 0.0037
777 GASTROINTESTINAL PAIN 41 0.0037
778 FOOT DEFORMITY 41 0.0037
779 RASH GENERALISED 95 0.0037
780 CARDIOMYOPATHY 54 0.0037
781 CARDIAC FAILURE 291 0.0036
782 FOLLICULITIS 38 0.0036
783 EYE PAIN 204 0.0036
784 PLEURAL EFFUSION 220 0.0036
785 PRODUCT DOSE OMISSION IN ERROR 102 0.0036
786 HELICOBACTER INFECTION 37 0.0036
787 MOOD ALTERED 98 0.0036
788 INCORRECT PRODUCT STORAGE 47 0.0036
789 PULMONARY OEDEMA 160 0.0036
790 ABSCESS 57 0.0036
791 VISUAL IMPAIRMENT 442 0.0036
792 HYPOPHAGIA 91 0.0036
793 RASH PAPULAR 79 0.0035
794 ARTHROPATHY 195 0.0035
795 DIABETES MELLITUS INADEQUATE CONTROL 62 0.0035
796 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 64 0.0035
797 THYROID CANCER 42 0.0035
798 AGITATION 256 0.0035
799 SKIN IRRITATION 158 0.0034
800 DISTURBANCE IN ATTENTION 186 0.0034
801 GLOSSODYNIA 77 0.0034
802 OESOPHAGITIS 37 0.0034
803 PRODUCT QUALITY ISSUE 458 0.0034
804 AGEUSIA 84 0.0034
805 BLINDNESS 137 0.0034
806 RESPIRATORY ARREST 92 0.0033
807 NERVOUS SYSTEM DISORDER 104 0.0033
808 HAEMATURIA 114 0.0033
809 INJECTION SITE HAEMORRHAGE 265 0.0033
810 INJECTION SITE INDURATION 43 0.0033
811 LOCAL SWELLING 57 0.0033
812 PULMONARY HYPERTENSION 68 0.0033
813 ORAL PAIN 73 0.0033
814 IMPAIRED HEALING 107 0.0033
815 HYPOTENSION 651 0.0032
816 NEOPLASM MALIGNANT 216 0.0032
817 DIPLOPIA 84 0.0032
818 HAEMORRHOIDS 63 0.0032
819 MOUTH ULCERATION 68 0.0032
820 RESTLESSNESS 118 0.0032
821 DEEP VEIN THROMBOSIS 209 0.0032
822 RESTLESS LEGS SYNDROME 58 0.0032
823 GASTRIC DISORDER 109 0.0032
824 CEREBROVASCULAR ACCIDENT 537 0.0032
825 BLOOD CREATININE INCREASED 206 0.0032
826 FEELING JITTERY 60 0.0031
827 DIARRHOEA 2008 0.0031
828 HAEMOGLOBIN DECREASED 319 0.0031
829 DECREASED APPETITE 721 0.0031
830 INJURY 218 0.0031
831 LEUKOCYTOSIS 56 0.0031
832 EMOTIONAL DISORDER 95 0.0031
833 CORONARY ARTERY OCCLUSION 42 0.0031
834 MOOD SWINGS 97 0.0030
835 EXPIRED PRODUCT ADMINISTERED 101 0.0030
836 FLUID RETENTION 154 0.0030
837 ABDOMINAL PAIN LOWER 76 0.0030
838 RETCHING 64 0.0030
839 GASTRIC ULCER 57 0.0030
840 RENAL DISORDER 139 0.0030
841 IRRITABILITY 178 0.0030
842 SEPSIS 330 0.0030
843 SKIN EXFOLIATION 249 0.0029
844 BASAL CELL CARCINOMA 46 0.0029
845 DYSMENORRHOEA 39 0.0029
846 URINARY INCONTINENCE 87 0.0029
847 MYOCARDIAL INFARCTION 512 0.0029
848 SKIN ULCER 75 0.0029
849 INJECTION SITE MASS 107 0.0029
850 INTESTINAL OBSTRUCTION 109 0.0029
851 BEDRIDDEN 38 0.0029
852 ANKYLOSING SPONDYLITIS 38 0.0029
853 HIP FRACTURE 92 0.0029
854 PERICARDIAL EFFUSION 66 0.0029
855 SEIZURE 329 0.0028
856 RESPIRATORY FAILURE 207 0.0028
857 JOINT RANGE OF MOTION DECREASED 38 0.0028
858 SINUS TACHYCARDIA 40 0.0028
859 EYE IRRITATION 162 0.0028
860 HAEMATOCRIT DECREASED 55 0.0028
861 CARDIOVASCULAR DISORDER 70 0.0028
862 BLOOD GLUCOSE DECREASED 132 0.0027
863 GALLBLADDER DISORDER 49 0.0027
864 ATRIAL FIBRILLATION 266 0.0027
865 INCREASED APPETITE 52 0.0027
866 UNEVALUABLE EVENT 204 0.0027
867 HEPATIC CIRRHOSIS 50 0.0027
868 EPILEPSY 81 0.0026
869 DEVICE USE ERROR 92 0.0026
870 DEVICE FAILURE 40 0.0026
871 RHEUMATOID ARTHRITIS 297 0.0026
872 MENSTRUATION IRREGULAR 70 0.0026
873 FAECES DISCOLOURED 56 0.0026
874 PRODUCT USE ISSUE 481 0.0026
875 PANCREATITIS 135 0.0026
876 OSTEOMYELITIS 46 0.0025
877 HEMIPARESIS 43 0.0025
878 FOETAL EXPOSURE DURING PREGNANCY 205 0.0025
879 INCORRECT ROUTE OF DRUG ADMINISTRATION 90 0.0025
880 ABASIA 62 0.0025
881 PAIN IN JAW 71 0.0025
882 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
883 HEPATIC ENZYME INCREASED 170 0.0025
884 BLOOD SODIUM DECREASED 47 0.0025
885 DRUG RESISTANCE 64 0.0025
886 LYMPHOCYTE COUNT DECREASED 44 0.0025
887 SHOCK 57 0.0025
888 ORTHOSTATIC HYPOTENSION 43 0.0025
889 BLOOD TRIGLYCERIDES INCREASED 43 0.0024
890 HAEMATOCHEZIA 132 0.0024
891 DRUG EFFECT DECREASED 128 0.0024
892 DEVICE LEAKAGE 103 0.0024
893 RED BLOOD CELL COUNT DECREASED 67 0.0023
894 ANAEMIA 446 0.0023
895 NIGHTMARE 80 0.0023
896 ACUTE MYOCARDIAL INFARCTION 68 0.0023
897 SKIN FISSURES 44 0.0022
898 PRODUCT PRESCRIBING ISSUE 48 0.0022
899 THERAPY INTERRUPTED 157 0.0022
900 SUICIDAL IDEATION 201 0.0022
901 DYSGEUSIA 162 0.0022
902 THERAPEUTIC RESPONSE UNEXPECTED 96 0.0021
903 BLOOD GLUCOSE INCREASED 401 0.0021
904 APHASIA 64 0.0021
905 ADVERSE DRUG REACTION 190 0.0021
906 AMENORRHOEA 37 0.0021
907 RENAL IMPAIRMENT 177 0.0021
908 LIVER DISORDER 93 0.0021
909 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 114 0.0021
910 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 70 0.0021
911 TASTE DISORDER 42 0.0021
912 COLITIS 78 0.0021
913 PNEUMONIA ASPIRATION 51 0.0020
914 NEUROPATHY PERIPHERAL 194 0.0020
915 BLOOD CREATINE PHOSPHOKINASE INCREASED 58 0.0020
916 DEMENTIA 56 0.0020
917 HYPOGLYCAEMIA 96 0.0020
918 HAEMATEMESIS 50 0.0020
919 VAGINAL HAEMORRHAGE 85 0.0020
920 CONFUSIONAL STATE 316 0.0020
921 APPLICATION SITE PAIN 43 0.0020
922 KNEE ARTHROPLASTY 41 0.0019
923 SEDATION 51 0.0019
924 PSORIASIS 254 0.0019
925 MEDICATION ERROR 108 0.0019
926 DISORIENTATION 76 0.0019
927 CONSTIPATION 417 0.0019
928 AGGRESSION 94 0.0019
929 FLATULENCE 103 0.0018
930 RECTAL HAEMORRHAGE 78 0.0018
931 SURGERY 105 0.0018
932 DEATH 1523 0.0018
933 THERAPY CESSATION 90 0.0018
934 MULTIPLE SCLEROSIS 83 0.0017
935 COLITIS ULCERATIVE 77 0.0017
936 CARDIAC ARREST 142 0.0017
937 COGNITIVE DISORDER 80 0.0017
938 CARDIAC FAILURE CONGESTIVE 137 0.0017
939 ANGER 57 0.0017
940 HEPATITIS 43 0.0017
941 JAUNDICE 45 0.0017
942 DRUG ADMINISTRATION ERROR 51 0.0017
943 CHROMATURIA 37 0.0016
944 COMA 77 0.0016
945 DEHYDRATION 213 0.0016
946 EMOTIONAL DISTRESS 192 0.0016
947 PSORIATIC ARTHROPATHY 64 0.0016
948 HOSPITALISATION 241 0.0016
949 ERECTILE DYSFUNCTION 40 0.0016
950 EXTRA DOSE ADMINISTERED 61 0.0015
951 URINARY RETENTION 50 0.0015
952 DRUG DEPENDENCE 237 0.0015
953 CORONARY ARTERY DISEASE 44 0.0015
954 INTERSTITIAL LUNG DISEASE 70 0.0014
955 OSTEONECROSIS 47 0.0014
956 FEMUR FRACTURE 41 0.0013
957 PANCREATIC CARCINOMA 38 0.0013
958 STOMATITIS 78 0.0013
959 RENAL FAILURE 162 0.0012
960 CEREBRAL HAEMORRHAGE 43 0.0012
961 HALLUCINATION 90 0.0012
962 CONVULSION 68 0.0012
963 BONE DENSITY DECREASED 37 0.0012
964 ALANINE AMINOTRANSFERASE INCREASED 72 0.0012
965 PRODUCT DOSE OMISSION 76 0.0012
966 DRUG DOSE OMISSION 192 0.0012
967 DYSKINESIA 47 0.0012
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 82 0.0012
969 PROSTATE CANCER 92 0.0011
970 CARDIO-RESPIRATORY ARREST 46 0.0011
971 DEPRESSED LEVEL OF CONSCIOUSNESS 43 0.0011
972 BRADYCARDIA 57 0.0011
973 ASPARTATE AMINOTRANSFERASE INCREASED 57 0.0011
974 SUICIDE ATTEMPT 62 0.0010
975 DEVICE DIFFICULT TO USE 67 0.0010
976 SEPTIC SHOCK 42 0.0010
977 DEVICE BREAKAGE 38 0.0009
978 INFUSION RELATED REACTION 60 0.0009
979 TREATMENT NONCOMPLIANCE 48 0.0009
980 THROMBOCYTOPENIA 98 0.0009
981 PLATELET COUNT DECREASED 88 0.0008
982 OVERDOSE 178 0.0008
983 WHITE BLOOD CELL COUNT DECREASED 88 0.0008
984 DISEASE PROGRESSION 93 0.0008
985 DRUG INTERACTION 120 0.0008
986 GASTROINTESTINAL HAEMORRHAGE 62 0.0007
987 CHRONIC KIDNEY DISEASE 50 0.0007
988 ADVERSE EVENT 57 0.0006
989 ACUTE KIDNEY INJURY 37 0.0002